![Romulus Brazzell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Romulus Brazzell
Hoofd Techniek/Wetenschap/O&O bij
KALA BIO, INC.
Vermogen: 436 $ op 30-06-2026
Profiel
Romulus Kim Brazzell is currently Director at Mimetogen Pharmaceuticals, Inc. since 2024 and Chief Medical Officer, Head-Research & Development at Kala Bio, Inc. since 2021.
Former positions include Associate Director-Research & Development at Alcon Laboratories, Inc. from 1990 to 1991; Executive VP-Medical & Scientific Affairs at Inspire Pharmaceuticals, Inc. from 2010 to 2011; Senior Vice President-US Research & Development at Novartis Ophthalmics, Inc. from 2000 to 2004; Chief Medical Officer at Mimetogen Pharmaceuticals, Inc. from 2012 to 2015; Vice President-Research & Development at Ciba Vision Ophthalmics Co. from 1996 to 2000; and Principal at Acuity Advisors LLC from 2014 to 2018.
Education includes undergraduate and doctorate degrees from the University of Kentucky.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 29-12-2025 | 252 ( 0% ) | 436 $ | 30-06-2026 |
Actieve functies van Romulus Brazzell
| Bedrijven | Functie | Begin |
|---|---|---|
| KALA BIO, INC. | Hoofd Techniek/Wetenschap/O&O | 01-02-2013 |
Mimetogen Pharmaceuticals, Inc.
 Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops peptidomimetic small molecule drugs against glaucoma and cancer | Directeur/Bestuurslid | 01-01-2024 |
Eerdere bekende functies van Romulus Brazzell
| Bedrijven | Functie | Einde |
|---|---|---|
Acuity Advisors LLC
 Acuity Advisors LLC Investment ManagersFinance Provides investment advice | Corporate Officer/Principal | 01-07-2018 |
Mimetogen Pharmaceuticals, Inc.
Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops peptidomimetic small molecule drugs against glaucoma and cancer | Hoofd Techniek/Wetenschap/O&O | 01-12-2015 |
Inspire Pharmaceuticals, Inc.
 Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic products | Hoofd Techniek/Wetenschap/O&O | 01-01-2011 |
Novartis Ophthalmics, Inc.
 Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, eye care and generic drugs | Hoofd Techniek/Wetenschap/O&O | 01-01-2004 |
Ciba Vision Ophthalmics Co. | Hoofd Techniek/Wetenschap/O&O | 01-01-2000 |
Opleiding van Romulus Brazzell
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
57
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes ophthalmic products | Health Technology |
Kala Bio, Inc.
 Kala Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing mesenchymal stem cell secretive (MSC-S) therapies | Health Technology |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Operates as an eye care device company | Health Technology |
University of Kentucky
 University of Kentucky Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Ophthalmics, Inc.
Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, eye care and generic drugs | Health Technology |
Mimetogen Pharmaceuticals, Inc.
Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops peptidomimetic small molecule drugs against glaucoma and cancer | Health Technology |
Ciba Vision Ophthalmics Co. | |
Acuity Advisors LLC
Acuity Advisors LLC Investment ManagersFinance Provides investment advice | Finance |
